PAPER Ren Y, Pieper AA, Cheng F
SEARCH RESULTS
346774 RESULTS
PAPER Prabakaran A, Rakshit D, Patel I, Susanna KJ, Mishra A, Radhakrishnanand P, Sarma P, Alexander A
Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in Aβ1-42 induced C57BL/6 mice for Alzheimer's disease treatment.
Int J Biol Macromol. 2025 Feb 16;:141136. Epub 2025 Feb 16 PubMed.PAPER Nesterov SV, Ilyinsky NS, Fonin AV, Uversky VN
Signal Transduction by Phase Separation-Unnoticed Revolution in Molecular Biology.
J Mol Recognit. 2025 Mar;38(2):e70003. PubMed.PAPER Wright AL, Weible AP, Estes OB, Wehr M
Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease.
Front Aging Neurosci. 2025;17:1505908. Epub 2025 Feb 3 PubMed.PAPER Lobyntseva A, Ganaiem M, Ivashko-Pachima Y, Barnstable CJ, Weisinger B, Parabucki A, Segal Y, Shohami E, Gozes I
Extremely Low-Frequency and Low-Intensity Electromagnetic Field Technology (ELF-EMF) Sculpts Microtubules.
Eur J Neurosci. 2025 Feb;61(4):e70023. PubMed.PAPER Jiao F, Wang Q, Zhong J, Lin H, Lu J, Wang L, Wang M, Liu F, Jiang J, Zuo C
Relationships Between Glymphatic System Activity and Tau Burden, Dopaminergic Impairment, Abnormal Glucose Metabolism in Progressive Supranuclear Palsy.
CNS Neurosci Ther. 2025 Feb;31(2):e70284. PubMed.PAPER Sakuragi S, Uchida T, Kato N, Zhao B, Takahashi T, Hattori A, Sakata Y, Soeda Y, Takashima A, Yoshimura H, Matsumoto G, Bannai H
Inducing aggresome and stable tau aggregation in Neuro2a cells with an optogenetic tool.
Biophys Physicobiol. 2024;21(4):e210023. Epub 2024 Oct 29 PubMed.PAPER Li B, Wang L, Xiao Y, Wang Y, Wang Y, Peng Y, Zhang A, Tang Z, Qi X
Gastrodin Ameliorates Tau Pathology and BBB Dysfunction in 3xTg-AD Transgenic Mice by Regulating the ADRA1/NF-κB/NLRP3 Pathway to Reduce Neuroinflammation.
Phytother Res. 2025 Feb 18; Epub 2025 Feb 18 PubMed.PAPER Singab AN, Talaat A, Ibrahim N, Ayoub I, Labib R
GC-MS Profiling of Crateva magna Leaf Lipophilic Extract and Evaluation of its Anti-Alzheimer and Cytotoxic Properties.
Chem Biodivers. 2025 Feb 18;:e202402770. Epub 2025 Feb 18 PubMed.PAPER Scholz K, Pattanayak R, Ekkatine R, Pair FS, Nobles A, Stone WJ, Yacoubian TA
Rab27b promotes lysosomal function and alpha-synuclein clearance in neurons.
J Neurosci. 2025 Feb 18; Epub 2025 Feb 18 PubMed.PAPER Zhang H, Zhang J, Jing X, Huang K, Chen Y, Shen Q, Tao E, Lin D
Microglia toxicology in α-synuclein pathology.
Biochim Biophys Acta Mol Basis Dis. 2025 Feb 16;:167727. Epub 2025 Feb 16 PubMed.PAPER Kim H, Kang S, Cho B, An S, Kim Y, Kim J
Parkinson's Disease Modeling Using Directly Converted 3D Induced Dopaminergic Neuron Organoids and Assembloids.
Adv Sci (Weinh). 2025 Feb 18;:e2412548. Epub 2025 Feb 18 PubMed.PAPER Hofman K, Chen JZ, Sil T, Pellegrini F, Haufe S, Pozzi N, Palmisano C, Isaias I, Koprich JB, Brotchie JM, Kühn AA, Matthies C, Reich MM, Muthuraman M, Volkmann J, Ip CW
Low β predicts motor output and cell degeneration in the A53T Parkinson's disease rat model.
Brain. 2025 Feb 18; Epub 2025 Feb 18 PubMed.PAPER Dai L, Wang J, Meng L, Zhang X, Xiao T, Deng M, Chen G, Xiong J, Ke W, Hong Z, Bu L, Zhang Z
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease.
PLoS Biol. 2025 Feb;23(2):e3002974. Epub 2025 Feb 18 PubMed.PAPER Tharp E, Martinez-Lemus JD, Schiess MC, Ellmore TM, Suescun J, Shahnawaz M
Role of alpha-synuclein seed amplification assay in Parkinson's disease clinical trials: A case of misdiagnosis.
Clin Park Relat Disord. 2024;11:100274. Epub 2024 Oct 5 PubMed.Current Filters
No filters selected